Home LiteratureArticle Details
PMID: 18521338 Published · ppublish English Journal Article

Differential Expression of IRS-1 and IRS-2 in Uterine Leiomyosarcomas with Distinct Oncogenic Phenotypes: Lack of Correlation with Downstream Signaling Events.

Sarcoma ·Vol. 6 ·No. 3 ·2002-00-00 ·Pages 89-96

Colombatti A, Russo P, Cervi M, Bogetto L, Wassermann B, Mainiero F, Spessotto P

Abstract

Insulin receptor substrates (IRSs) are essential for insulin-induced mitogenic effects on several cell types but they also are involved in cell transformation.We investigated whether the differential constitutive expression and potential distinct downstream signaling events of IRS-1 and IRS-2 might be related to discrete tumourigenic phenotypes of three human uterine leiomyosarcoma cell lines, one of which was specifically isolated for the present study. SK-UT-1B egressed effectively from a gellyfied Matrigel matrix and grew as did DMR cells in an anchorage-independent manner in agar and induced rapidly growing tumours in nude mice. On the contrary, SK-LMS-1 cells did not emigrate from Matrigel, neither grew in agar nor were they tumourigenic. IRS-2 was highly expressed in the more malignant cell lines, whereas IRS-1 was present only in SK-LMS-1 cells. However, upon insulin stimulation both IRS- 1 and IRS-2 were tyrosine phosphorylated with a similar kinetic in the respective cell lines; furthermore, after 1 min of insulin stimulation PI3-kinase associated with IRSs and after 2 min Shc was phosphorylated and associated with Grb2 with minor differences detectable among the various cell lines in the duration of phosphorylation and/or in their association irrespective of whether IRS-1 or IRS-2 were expressed. Our findings tend to exclude that the malignancy displayed by uterine leiomyosarcomas might be directly linked to the activation of distinct IRS-1- or IRS-2-dependent pathways.

Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Colombatti Alfonso
Divisione di Oncologia Sperimentale 2 Centro di Riferimento Oncologico-IRCCS Aviano 33081 Italy.
Russo Pietro
Cervi Marta
Bogetto Laura
Wassermann Bruna
Mainiero Fabrizio
Spessotto Paola
References (29)
29 references, click to expand
  1. Overexpression of insulin receptor substrate 1 (IRS-1) in the human breast cancer cell line MCF-7 induces loss of estrogen requirements for growth and transformation.
    Clin Cancer Res. 1995 Nov;1(11):1429-36 PMID: 9815941
  2. The influence of glucocorticoids on the growth of a human leiomyosarcoma cell line SK-LMS-1.
    Int J Cancer. 1989 Dec 15;44(6):1034-40 PMID: 2606572
  3. Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes.
    Mol Endocrinol. 1998 May;12(5):688-97 PMID: 9605931
  4. Neoplastic transformation induced by insulin receptor substrate-1 overexpression requires an interaction with both Grb2 and Syp signaling molecules.
    J Biol Chem. 1996 Jun 14;271(24):14610-6 PMID: 8662827
  5. Disruption of IRS-2 causes type 2 diabetes in mice.
    Nature. 1998 Feb 26;391(6670):900-4 PMID: 9495343
  6. Intracellular localization of phosphatidylinositide 3-kinase and insulin receptor substrate-1 in adipocytes: potential involvement of a membrane skeleton.
    J Cell Biol. 1998 Mar 9;140(5):1211-25 PMID: 9490733
  7. Contrasting effects of IRS-1 versus IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo.
    J Biol Chem. 2000 Dec 15;275(50):38990-4 PMID: 10995761
  8. Pathology and pathophysiology of uterine smooth-muscle tumors.
    Environ Health Perspect. 2000 Oct;108 Suppl 5:779-84 PMID: 11035982
  9. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein.
    Nature. 1991 Jul 4;352(6330):73-7 PMID: 1648180
  10. Dynamics of insulin signaling in 3T3-L1 adipocytes. Differential compartmentalization and trafficking of insulin receptor substrate (IRS)-1 and IRS-2.
    J Biol Chem. 1998 May 8;273(19):11548-55 PMID: 9565570
  11. The pathology of uterine smooth muscle tumors and mixed endometrial stromal-smooth muscle tumors: a selective review with emphasis on recent advances.
    Int J Gynecol Pathol. 2000 Jan;19(1):39-55 PMID: 10638452
  12. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2.
    J Clin Invest. 2000 Jan;105(2):199-205 PMID: 10642598
  13. Signalling through the insulin receptor.
    Curr Opin Cell Biol. 2000 Apr;12(2):222-8 PMID: 10712920
  14. Release of insulin receptor substrate proteins from an intracellular complex coincides with the development of insulin resistance.
    J Biol Chem. 2000 Feb 11;275(6):3819-26 PMID: 10660532
  15. Smooth muscle neoplasms of the uterus other than ordinary leiomyoma. A study of 46 cases, with emphasis on diagnostic criteria and prognostic factors.
    Cancer. 1988 Nov 15;62(10):2239-47 PMID: 3179938
  16. Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes.
    Diabetes. 1994 Aug;43(8):1066-84 PMID: 8039601
  17. Insulin receptor substrate 1 rescues insulin action in CHO cells expressing mutant insulin receptors that lack a juxtamembrane NPXY motif.
    Mol Cell Biol. 1995 Sep;15(9):4711-7 PMID: 7651388
  18. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene.
    Nature. 1994 Nov 10;372(6502):186-90 PMID: 7526222
  19. Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling.
    Biochem J. 1998 Aug 1;333 ( Pt 3):471-90 PMID: 9677303
  20. SK-UT-1B, a human tumorigenic diploid cell line.
    Cancer Genet Cytogenet. 1988 Jul 1;33(1):77-81 PMID: 3383166
  21. Overexpression of insulin receptor substrate-1 emerges early in hepatocarcinogenesis and elicits preneoplastic hepatic glycogenosis.
    Am J Pathol. 1998 Feb;152(2):341-5 PMID: 9466558
  22. Insulin signalling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice.
    Mol Cell Biol. 1996 Jun;16(6):3074-84 PMID: 8649419
  23. Signal transduction through MAP kinase cascades.
    Adv Cancer Res. 1998;74:49-139 PMID: 9561267
  24. Role of IRS-2 in insulin and cytokine signalling.
    Nature. 1995 Sep 14;377(6545):173-7 PMID: 7675087
  25. PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model.
    Hum Mol Genet. 2001 Mar 15;10(6):605-16 PMID: 11230180
  26. Enhanced expression of the insulin receptor substrate-2 docking protein in human pancreatic cancer.
    Cancer Res. 1998 Oct 1;58(19):4250-4 PMID: 9766646
  27. Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study.
    Cancer. 1993 Feb 15;71(4 Suppl):1702-9 PMID: 8381710
  28. A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family.
    J Biol Chem. 1997 Aug 22;272(34):21403-7 PMID: 9261155
  29. Down-regulation of insulin-like growth factor-I receptor and insulin receptor substrate-1 expression in advanced human breast cancer.
    Int J Cancer. 2000 Nov 20;89(6):506-13 PMID: 11102895
Article Info
Journal
Sarcoma
Abbr.
Sarcoma
ISSN
1357-714X
Published
2002-00-00
Pages
89-96
Language
English
Region
Egypt
NLM ID
9709257
PMCID
PMC2395487
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com